{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T02:29:24Z","timestamp":1782613764616,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.vaccine.2005.08.010","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T11:34:22Z","timestamp":1124451262000},"page":"4461-4470","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy"],"prefix":"10.1016","volume":"24","author":[{"given":"Miguel","family":"Otero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Calarota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anlan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"De Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean D.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2005.08.010_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines","volume":"7","author":"Rosenthal","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2005.08.010_bib2","first-page":"492","article-title":"Complications of vaccination against smallpox","volume":"76","author":"Greenberg","year":"1948","journal-title":"Am J Dis Child"},{"issue":"6","key":"10.1016\/j.vaccine.2005.08.010_bib3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1542\/peds.39.6.916","article-title":"Complications of smallpox vaccination United States","volume":"39","author":"Neff","year":"1967","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2005.08.010_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM196701192760301","article-title":"Complications of smallpox vaccination","volume":"276","author":"Neff","year":"1967","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2005.08.010_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1542\/peds.50.3.481","article-title":"Complications of smallpox vaccination, 1968 surveillance in a comprehensive care clinic","volume":"50","author":"Neff","year":"1972","journal-title":"Pediatrics"},{"issue":"22","key":"10.1016\/j.vaccine.2005.08.010_bib6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJM196911272812205","article-title":"Routine childhood vaccination against smallpox reconsidered","volume":"281","author":"Lane","year":"1969","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2005.08.010_bib7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","article-title":"Complications of smallpox vaccination","volume":"281","author":"Lane","year":"1969","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.010_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/infdis\/122.4.303","article-title":"Complications of smallpox vaccination, 1968: results of ten statewide surveys","volume":"122","author":"Lane","year":"1970","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.08.010_bib9","unstructured":"Fulginiti VA, Kempe CH, Hathaway WE, Pearlman DS, Sieber OF, Eller JJ, et al. Progressive vaccinia in immunologically deficient individuals. New York: The National Foundation-March of Dimes, Birth Defects, Original Article Series, Immunologic Deficiency Diseases in Man 1968;4:129\u201345."},{"issue":"25","key":"10.1016\/j.vaccine.2005.08.010_bib10","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJM195806192582507","article-title":"Acute pericarditis after smallpox vaccination","volume":"258","author":"Cangemi","year":"1958","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.010_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM196901092800223","article-title":"Postvaccination arthritis","volume":"280","author":"Holtzman","year":"1969","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.010_bib12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/archderm.97.4.400","article-title":"Malignant tumors in smallpox vaccination scars: a report of 24 cases","volume":"97","author":"Marmelzat","year":"1968","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.vaccine.2005.08.010_bib13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/bmj.2.5414.906","article-title":"Eczema vaccinatum","volume":"5414","author":"Copeman","year":"1964","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.vaccine.2005.08.010_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jama.212.3.441","article-title":"Death attributable to smallpox vaccination, 1959 to 1966, and 1968","volume":"212","author":"Lane","year":"1970","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.vaccine.2005.08.010_bib15","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.90.9.4156","article-title":"Gene inoculation generates immune responses against human immunodeficiency virus type 1","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2005.08.010_bib16","first-page":"S43","article-title":"Accell particle-mediated DNA immunization elicits humoral, cytotoxic and protective responses","volume":"10","author":"Haynes","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.010_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/viro.1995.1238","article-title":"Use of DNAs expressing HIV-1 Env and non-infectious HIV-1 particles to raise antibody responses in mice","volume":"209","author":"Lu","year":"1995","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2005.08.010_bib18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nm0597-526","article-title":"Protection of chimpanzees from high dose heterologous HIV-1 challenge by DNA vaccination","volume":"3","author":"Boyer","year":"1997","journal-title":"Nat Med"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2005.08.010_bib19","first-page":"S35","article-title":"DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells","volume":"10","author":"Wang","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"17","key":"10.1016\/j.vaccine.2005.08.010_bib20","doi-asserted-by":"crossref","first-page":"9378","DOI":"10.1073\/pnas.94.17.9378","article-title":"Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination","volume":"94","author":"Letvin","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.010_bib21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/JVI.70.1.678-681.1996","article-title":"Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys","volume":"70","author":"Yasutomi","year":"1996","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.010_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/515613","article-title":"First human trial of a DNA-based vaccine for the treatment of HIV-1 infection: safety and host responses","volume":"178","author":"MacGregor","year":"1998","journal-title":"J Infect Dis"},{"issue":"9112","key":"10.1016\/j.vaccine.2005.08.010_bib23","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0140-6736(97)09440-3","article-title":"Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients","volume":"351","author":"Calarota","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.010_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/clim.1998.4616","article-title":"Enhancement of cellular immune response in HIV-1 seropositive individuals: a DNA-based trial","volume":"90","author":"Boyer","year":"1999","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.010_bib25","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.4049\/jimmunol.163.4.2330","article-title":"Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment","volume":"163","author":"Calarota","year":"1999","journal-title":"J Immunol"},{"issue":"16","key":"10.1016\/j.vaccine.2005.08.010_bib26","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200211080-00005","article-title":"T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev","volume":"16","author":"MacGregor","year":"2002","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.vaccine.2005.08.010_bib27","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1128\/JVI.61.11.3550-3554.1987","article-title":"Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein","volume":"61","author":"Rodriguez","year":"1987","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.010_bib28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JVI.66.1.386-398.1992","article-title":"Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"66","author":"Demkowicz","year":"1992","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.010_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0042-6822(88)90096-7","article-title":"Molecular characterization of a prominent antigen of the vaccinia virus envelope","volume":"167","author":"Gordon","year":"1988","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2005.08.010_bib30","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1128\/JVI.61.12.3910-3919.1987","article-title":"Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus","volume":"61","author":"Maa","year":"1987","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2005.08.010_bib31","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1128\/JVI.70.10.6796-6802.1996","article-title":"The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression","volume":"70","author":"Kovacs","year":"1996","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2005.08.010_bib32","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1128\/JVI.70.10.6909-6921.1996","article-title":"A vaccinia virus core protein, p39, is membrane associated","volume":"70","author":"Cudmore","year":"1996","journal-title":"J Virol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2005.08.010_bib33","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.vaccine.2005.01.012","article-title":"The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program","volume":"23","author":"Poland","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.010_bib34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/JVI.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodriguez","year":"1985","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2005.08.010_bib35","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1128\/JVI.72.12.10126-10137.1998","article-title":"The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal a-helix","volume":"72","author":"Vazquez","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.010_bib36","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2005.08.010_bib37","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.vaccine.2004.02.034","article-title":"Differential efficacy of vaccinia virus envelope proteins administered by DNA immunization in protection of BALB\/c mice from a lethal intranasal poxvirus challenge","volume":"22","author":"Pulford","year":"2004","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2005.08.010_bib38","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05008054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05008054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T07:21:30Z","timestamp":1683184890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05008054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":38,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0264410X05008054"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.08.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}